Purification method optimization of recombinant basic fibroblast growth factor rhfgf-2 expressed in methylotrophic yeast Pichia pastoris

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Basic human fibroblast growth factor FGF-2 plays a major role in wound healing. Thus, its regenerative potential attracts both researchers and commercial drug manufacturers, including cell therapy developers. This research aims to optimize purification method to obtain high purity rhFGF-2 expressed in methylotrophic yeast Pichia pastoris. Suggested method allows purification of rhFGF-2 with purity of >98% as determined by SDS-PAGE. The effective proliferative dose of rhFGF-2 determined by WST-1 proliferative assay on 3T3 mouse fibroblast cell culture is 5.73 ± 2.16 ng/ml. The presented optimized technique may be attractive for the development of an industrial technology for rhFGF-2 production.

Sobre autores

A. Misterova

Vyatka State University

Email: usr21438@vyatsu.ru
Kirov, 610000 Russia

A. Gerasimov

Vyatka State University

Autor responsável pela correspondência
Email: usr21438@vyatsu.ru
Kirov, 610000 Russia

Bibliografia

  1. Zhang D., Mai Q., Li T., Huang J., Ding C., Jia M. et al. // Stem Cell Res. Ther. 2016. V. 7. № 1. https://doi.org/10.1186/s13287-016-0347-7
  2. Estapé D., Heuvel J.V.D., Rinas U. // Biochem. J. 1998. V. 335. № 2. P. 343–349.
  3. Chen R., John J., Lavrentieva A., Müller S., Tomala M., Zhao Y. et al. // Engineering in Life Sciences. 2012. V. 12. № 1. P. 29 –38.
  4. Mu X., Kong N., Chen W., Zhang T., Shen M., Yan W. // Protein Expr. Purif.. 2008. V. 59. № 2. P. 282–288.
  5. Sauer D.G., Mosor M., Frank A.C., Weiß F., Christler A., Walch N. et al. // Protein Expr. Purif.. 2019. V. 153. P. 70–82.
  6. Патент РФ . 2023. № 2804544.
  7. Garcia-Ortega X., Adelantado N., Ferrer P., Montesinos J.L., Valero F. // Process Biochemistry. 2016. V. 51. № 6. P. 681–691.
  8. Sauer D.G., Mosor M., Jungbauer A., Dürauer A. // Sep . Purif. Technol. 2021. V. 254. https://doi.org/10.1016/j.seppur.2020.117564
  9. Мистерова А.-А.В., Чичерин В.А., Герасимов А.С. // Прикл. биохимия и микробиология. 2023. T. 59. № 4. C. 383–391.
  10. Bolten S.N., Knoll A.S., Li Z., Gellermann P., Pepelanova I., Rinas U. et al. // Journal of Chromatography A. 2020. V. 1626. https://doi.org/10.1016/j.chroma.2020.461367
  11. Abdelhakim M., Lin X., Ogawa R. // Dermatol. Ther . (Heidelb.). 2020. V. 10. № 4. P. 569– 587.
  12. Kanemaru S. // Operative Techniques in Otolaryngology-Head and Neck Surgery. 2021. V. 32. № 2. P. 111–115.
  13. Nagayasu-Tanaka T., Anzai J., Takedachi M., Kitamura M., Harada T., Murakami S. // Regenerative Therapy. 2023. V. 23. P. 84–93.
  14. Fu X. Regenerative Medicine in China. / Ed. Fu X. Singapore: Springer Singapore, 2021. 485 p.
  15. Zheng K., Feng G., Zhang J., Xing J., Huang D., Lian M. et al. // Int. J. Neurosci. 2021. V. 131. № 7. P. 625–633.
  16. Moghtader F., Tabata Y., Karaöz E. // Gels. 2024. V. 10 . № 8. https://doi.org/10.3390/gels10080493
  17. Chen B., He J., Yang H., Zhang Q., Zhang L., Zhang X. et al. // Sci Rep. 2015. V. 5. № 1. https:// doi.org/10.1038/srep09017
  18. Kona S., Dong J.F., Liu Y., Tan J., Nguyen K.T. // Int. J. Pharm. 2012. V. 423. № 2. P. 516 –524.
  19. Auletta J.J., Zale E.A., Welter J.F., Solchaga L.A. // Stem Cells International. 2011. V . 3. https :// doi . org /10.4061/2011/235176

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Russian Academy of Sciences, 2025

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).